Detalles de la búsqueda
1.
The p53 Saga: Early Steps in the Development of Tumor Immunotherapy.
J Immunol
; 204(9): 2321-2328, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32312843
2.
Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Cell Commun Signal
; 18(1): 36, 2020 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32138738
3.
Correction to: Induction of immunogenic cell death in radiation-resistant breast cancer stem cells by repurposing anti-alcoholism drug disulfiram.
Cell Commun Signal
; 18(1): 53, 2020 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32241283
4.
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and tumor microenvironment, overcoming multiple obstacles of CAR T therapy for solid tumors.
Res Sq
; 2023 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36865255
5.
Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment.
Nat Commun
; 14(1): 5727, 2023 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37714830
6.
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients.
Cancer Immunol Immunother
; 61(3): 373-84, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21927947
7.
17ß Hydroxysteroid dehydrogenase type 12 (HSD17B12) is a marker of poor prognosis in ovarian carcinoma.
Gynecol Oncol
; 127(3): 587-94, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22903146
8.
Improving the Therapeutic Efficacy of Sorafenib for Hepatocellular Carcinoma by Repurposing Disulfiram.
Front Oncol
; 12: 913736, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35912209
9.
Identification of Hydroxysteroid (17ß) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas.
Cancer Immunol Immunother
; 60(7): 919-29, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21409596
10.
Targeting cancer stem cells by disulfiram and copper sensitizes radioresistant chondrosarcoma to radiation.
Cancer Lett
; 505: 37-48, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33582212
11.
Disulfiram Acts as a Potent Radio-Chemo Sensitizer in Head and Neck Squamous Cell Carcinoma Cell Lines and Transplanted Xenografts.
Cells
; 10(3)2021 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33671083
12.
Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells.
Mol Cancer Ther
; 20(3): 577-588, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653946
13.
CD8+ T cell recognition of polymorphic wild-type sequence p53(65-73) peptides in squamous cell carcinoma of the head and neck.
Cancer Immunol Immunother
; 59(10): 1561-8, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20577877
14.
Identification of a 17beta-hydroxysteroid dehydrogenase type 12 pseudogene as the source of a highly restricted BALB/c Meth A tumor rejection peptide.
Cancer Immunol Immunother
; 59(1): 113-24, 2010 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19562340
15.
CD4+ T cell responses to HLA-DP5-restricted wild-type sequence p53 peptides in patients with head and neck cancer.
Cancer Immunol Immunother
; 58(9): 1441-8, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19184003
16.
Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiram.
Am J Cancer Res
; 9(6): 1266-1281, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31285958
17.
Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer.
Sci Rep
; 8(1): 10716, 2018 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30013227
18.
P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells.
Cancer Res
; 63(13): 3675-81, 2003 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12839958
19.
Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.
Cancer Res
; 62(12): 3521-9, 2002 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12067999
20.
Targeting cancer stem cells with p53 modulators.
Oncotarget
; 7(29): 45079-45093, 2016 Jul 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-27074569